Gerd D. Bartoszyk
Merck KGaA
Department of CNS Research
Darmstadt
Germany
Name/email consistency: high
- Sarizotan, a serotonin 5-HT1A receptor agonist and dopamine receptor ligand. 1. Neurochemical profile. Bartoszyk, G.D., Van Amsterdam, C., Greiner, H.E., Rautenberg, W., Russ, H., Seyfried, C.A. J. Neural. Transm (2004)
- EMD 281014, a new selective serotonin 5-HT2A receptor antagonist. Bartoszyk, G.D., van Amsterdam, C., Böttcher, H., Seyfried, C.A. Eur. J. Pharmacol. (2003)
- Anxiolytic effects of dopamine receptor ligands: I. Involvement of dopamine autoreceptors. Bartoszyk, G.D. Life Sci. (1998)